The Business Research Company has recently released a significant report casting light on the global infection prevention market. This in-depth study provides valuable insights into market size, growth rates, regional shares, competition analyses, detailed segments, and potential opportunities.
The global infection prevention market size anticipates a steady growth curve, forecasted to reach $50.21 billion by 2028 at a compound annual growth rate (CAGR) of 3.7%. This projected acceleration over the coming years can be attributed to factors such as the emergence of new infectious diseases, innovative technological advancements, global population growth, and a surge in ambulatory care services.
Moreover, the market landscape is evolving under the influence of emerging trends such as telemedicine, digital health solutions, personalized infection prevention strategies, increased employment of artificial intelligence (AI) in the healthcare sector, rapid diagnostic procedures, and a honing focus on behavioral interventions. Leading companies contributing to the expansion and dynamic nature of the infection prevention market include well-established names such as Cardinal Health Inc., 3M Company, Stryker Corporation, Reckitt Benckiser Group plc, and Ecolab Inc., amongst others.
A projected driver forecasted to spur market growth is the increase in hospital-acquired infections. These infections, contracted during healthcare treatments, highlight the necessitation for effective prevention strategies to enhance patient safety. With Staphylococcus aureus bloodstream infections and MSSA infections on the rise in hospitals, companies are pressed to develop innovative solutions to aid infection prevention.
A recent innovation introduced by The Association for Professionals in Infection Control and Epidemiology is an infection preventionist staffing calculator. This tool supports healthcare facilities in identifying the optimal number of infection preventionists required to ensure effective infection control and improved patient safety.
The report proffers a comprehensive segmentation of the market by product (including sterilization equipment, disinfectors, consumables), infection type ( microbial infections, healthcare-associated infections), and end-user groups (hospitals and clinics, pharmaceutical companies, clinical laboratories, medical device companies, life science industry, academic and research center). For those interested in this field, the report constitutes an invaluable resource, providing detailed analysis and robust data demonstrating pertinent trends and future market opportunities.